|
A case of Thrombotic Thrombocytopenic Purpura following the AstraZeneca Vaccine
|
Effat Iranijam *    , Mohammad Hossein Hosseini , Mohammad Negaresh , Elham Yousefi Ardabili |
| Department of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran |
|
|
Abstract: (858 Views) |
A severe acute respiratory syndrome caused by coronavirus 2 infection (COVID-19)was identified in December 2019 and caused a massive pandemic that claimed millions of lives worldwide. The Chimpanzee adenovirus vector vaccine is one of the few vaccines against coronavirus disease in 2020. This case report introduces, a patient who developed thrombocytopenia, fever, and lethargy nine days after vaccination with the chimpanzee adenovirus carrier vaccine. The patient was admitted to the hospital and thrombotic thrombocytopenic purpura (TTP) symptoms appeared during hospitalization.
|
Article number: 8 |
| Keywords: Thrombotic Thrombocytopenic Purpura, Vaccine, ChAdOx1, COVID-19, AZD-1222 |
|
|
Full-Text [PDF 880 kb]
(433 Downloads)
|
Type of Study: case report |
Subject:
Hematology and oncology
Received: 2022/11/7 | Accepted: 2023/02/10 | Published: 2023/03/16
|
|
|
|
|
|
|
| Add your comments about this article |
|
|
|
.png)
.png)
